Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 4/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 4/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.39 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL319488 | 0.97 | APOBEC3A (0.42) | APOBEC3AAPOBEC3GPABPC1EIF4HKDM4E | |
| SCHEMBL15157545 | 0.95 | APOBEC3A (0.41) | APOBEC3AAPOBEC3GPABPC1EIF4HKDM4E | |
| Bromide SCHEMBL15157313 | 0.95 | TP53 (0.41) | APOBEC3AAPOBEC3GPABPC1EIF4HKDM4E | |
| SCHEMBL15395799 | 0.80 | — | — | |
| SCHEMBL4901634 | 0.78 | APOBEC3A (0.46) | APOBEC3AAPOBEC3GPABPC1EIF4HKDM4E | |
| SCHEMBL12500774 | 0.76 | PABPC1 (0.36) | APOBEC3AAPOBEC3GPABPC1EIF4HKDM4E | |
| SCHEMBL10256855 | 0.76 | PABPC1 (0.38) | APOBEC3AAPOBEC3GPABPC1 | |
| Water SCHEMBL1356208 | 0.76 | APOBEC3A (0.44) | APOBEC3AAPOBEC3GPABPC1EIF4HKDM4E | |
| SCHEMBL12500718 | 0.76 | PABPC1 (0.36) | APOBEC3AAPOBEC3GPABPC1EIF4HKDM4E | |
| SCHEMBL4901033 | 0.76 | APOBEC3A (0.48) | APOBEC3AAPOBEC3GPABPC1EIF4HKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312245-B2 | Method for manufacture of co-crystallized zeolite beta and zeolite mordenite in the presence of ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2025-05-27 | — | — | US | claimed |
| WO-2025080821-A1 | METHODS OF MODIFYING ZEOLITE BETA MATERIALS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-04-17 | — | — | WO | claimed |
| US-20250121364-A1 | METHODS OF MAKING ZEOLITE BETA MATERIALS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-04-17 | — | — | US | claimed |
| US-11827523-B2 | Method for manufacture of zeolite beta in the presence of ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2023-11-28 | — | — | US | claimed |
| US-20230331565-A1 | METHOD FOR MANUFACTURE OF ZEOLITE BETA IN THE PRESENCE OF ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2023-10-19 | — | — | US | claimed |
| US-20230331563-A1 | METHOD FOR MANUFACTURE OF CO-CRYSTALLIZED ZEOLITE BETA AND ZEOLITE MORDENITE IN THE PRESENCE OF ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2023-10-19 | — | — | US | claimed |
| US-11788171-B2 | Methods of recovering an elemental rare earth metal, and methods of forming a rare earth metal | BATTELLE ENERGY ALLIANCE, LLC (US) | 2023-10-17 | — | — | US | claimed |
| US-11149356-B2 | Methods of forming metals using ionic liquids | BATTELLE ENERGY ALLIANCE, LLC (US) | 2021-10-19 | — | — | US | claimed |
| US-20210292870-A1 | METHODS OF RECOVERING AN ELEMENTAL RARE EARTH METAL, METHODS OF FORMING A RARE EARTH METAL, AND RELATED SYSTEMS | UNITED STATES DEPARTMENT OF ENERGY | 2021-09-23 | — | — | US | claimed |
| US-20190186031-A1 | METHODS OF FORMING METALS USING IONIC LIQUIDS | UNITED STATES DEPARTMENT OF ENERGY | 2019-06-20 | — | — | US | claimed |
| US-20150048275-A1 | USE OF AN IONIC LIQUID FOR STORING HYDROGEN | PROIONIC GMBH (AT) | 2015-02-19 | — | — | US | claimed |
| EP-2809611-A1 | USE OF AN IONIC LIQUID FOR STORING HYDROGEN | VTU Holding GmbH (AT) | 2014-12-10 | — | — | EP | claimed |
| WO-2013113452-A1 | USE OF AN IONIC LIQUID FOR STORING HYDROGEN | VTU HOLDING GMBH (AT) | 2013-08-08 | — | — | WO | claimed |
| EP-2623457-A1 | Use of an ionic liquid for storing hydrogen | VTU Holding GmbH (AT) | 2013-08-07 | — | — | EP | claimed |
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | WILLIAMS RICHARD KENT (US) | 2026-04-30 | — | — | US | disclosed |
| US-12522509-B2 | Method to co-synthesize amorphous and crystalline materials in the presence of ODSO | SAUDI ARABIAN OIL COMPANY (SA) | 2026-01-13 | — | — | US | disclosed |
| US-12410062-B2 | Method to synthesize crystalline materials in the presence of ODSO with improved zeolite crystallization rates and enhanced relative crystallinity | SAUDI ARABIAN OIL COMPANY (SA) | 2025-09-09 | — | — | US | disclosed |
| US-20100311615-A1 | METHOD FOR SYNTHESIS OF TITANIUM DIOXIDE NANOTUBES USING IONIC LIQUIDS | UT-BATTELLE, LLC (US) | 2010-12-09 | — | — | US | disclosed |
| US-20090018105-A1 | Means and Methods for the Treatment and Prevention of Allergic Diseases | JADO TECHNOLOGIES GMBH | 2009-01-15 | — | — | US | disclosed |
| US-20060186419-A1 | Light-emitting device | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | MYOC, MB, MYOF | APOBEC3A 4145/4885APOBEC3G 3738/4885PABPC1 2912/4885 |
| US-20090018105-A1 | Means and Methods for the Treatment and Prevention of Allergic Diseases | PHOSPHO1, CPA3, SMPD3 | APOBEC3A 2202/4885APOBEC3G 2085/4885PABPC1 2437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.